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Abstract
Background: The large-scale production of G-protein coupled receptors (GPCRs) for functional
and structural studies remains a challenge. Recent successes have been made in the expression of
a range of GPCRs using Pichia pastoris as an expression host. P. pastoris has a number of advantages
over other expression systems including ability to post-translationally modify expressed proteins,
relative low cost for production and ability to grow to very high cell densities. Several previous
studies have described the expression of GPCRs in P. pastoris using shaker flasks, which allow
culturing of small volumes (500 ml) with moderate cell densities (OD600 ~15). The use of
bioreactors, which allow straightforward culturing of large volumes, together with optimal control
of growth parameters including pH and dissolved oxygen to maximise cell densities and expression
of the target receptors, are an attractive alternative. The aim of this study was to compare the
levels of expression of the human Adenosine 2A receptor (A2AR) in P. pastoris under control of a
methanol-inducible promoter in both flask and bioreactor cultures.
Results: Bioreactor cultures yielded an approximately five times increase in cell density (OD600
~75) compared to flask cultures prior to induction and a doubling in functional expression level per
mg of membrane protein, representing a significant optimisation. Furthermore, analysis of a C-
terminally truncated A2AR, terminating at residue V334 yielded the highest levels (200 pmol/mg) so
far reported for expression of this receptor in P. pastoris. This truncated form of the receptor was
also revealed to be resistant to C-terminal degradation in contrast to the WT A2AR, and therefore
more suitable for further functional and structural studies.
Conclusion:  Large-scale expression of the A2AR in P. pastoris bioreactor cultures results in
significant increases in functional expression compared to traditional flask cultures.
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Background
G-protein-coupled receptors (GPCRs) form a large super-
family of cell-surface receptors that mediate cellular
responses to a wide range of biologically active molecules
including hormones, neurotransmitters and drugs.
Indeed, half of all currently available pharmaceuticals act
through GPCRs [1,2]. The physiological and pharmaco-
logical importance of these proteins makes them key tar-
gets for drug discovery programmes. Our understanding
of the precise mechanism of action of these important
proteins is currently limited by a lack of high-resolution
structural data. One limiting factor to structural studies of
GPCRs has, until recently, been low expression levels [3].
With the exception of rhodopsin, all GPCRs are expressed
at very low levels endogenously, thus requiring the devel-
opment of recombinant overexpression systems. Careful
expression vector design, GPCR codon-optimisation [4]
and high throughput approaches used to identify GPCRs
with the highest expression levels in different expression
systems [5] are among the methods that have been used
to produce sufficiently high levels of functional GPCRs
suitable for structural studies.
Success has been achieved when using the expression host
Pichia pastoris for the production of membrane proteins
for structural studies, most notably the rat membrane pro-
tein K+ channel [6]. Pichia  has several advantages over
other systems for the production of GPCRs. It is easy to
manipulate, has high production levels and is relatively
inexpensive. In addition, Pichia has the ability to glyco-
sylate expressed receptors, albeit in a modified form com-
pared to higher eukaryotes, which is essential for the
proper functioning and membrane targeting of many
receptors [7-10]. Much effort has been applied to the opti-
misation of Pichia  expression systems specifically for
GPCR production [11-16]. The basic system uses a
pPIC9K vector (Invitrogen) where GPCR expression is
under the control of the strong methanol inducible AOX1
promoter. Protease deficient expression strains, such as
the SMD1163 strain, and the use of the α-factor leader
sequence have improved receptor expression levels
[11,12]. Modifications to the growth media including
addition of histidine, receptor specific ligands and dime-
thyl sulfoxide, which facilitates phospholipid biosynthe-
sis and membrane proliferation in yeast [17] have been
shown to increase the expression levels of 20 different
GPCRs in Pichia [15]
An additional advantage to the use of Pichia is that it read-
ily adapts to large-scale culture in bioreactors [18]. Biore-
actors allow precise regulation of the aeration, pH and
addition of carbon source, which in turn allows the cul-
tures to grow to ultra-high cell densities maximising
expression of the target protein. However optimisation of
standard protocols is usually necessary for specific targets.
One particular issue is the amount of methanol added for
induction. Indeed, very high levels of methanol can
induce cytotoxic effects which reduce cell viability and
thus expression [19]. Methanol sensors, which detect the
level of unmetabolised methanol have been key to reduc-
ing these cytotoxic effects. Another important issue to
consider is the osmotic stress induced during high cell
density culturing which is known to be responsible for
adaptative cell response mechanisms, such as changes in
the membrane lipid content [20]. This may not be desira-
ble in the process of membrane protein production and
medium cell density culturing approach may appear more
suitable. One aim of this study was to develop a protocol
for the large scale expression of GPCRs in P. pastoris using
bioreactors. The target GPCR used for development and
characterisation of the protocol was the human Adenos-
ine A2A receptor (A2AR), one of four receptors mediating
the effects of adenosine. The A2AR is key in downregula-
tion of immune responses in vivo and this in turn prevents
inflammatory damage of healthy tissue [21]. In addition,
it has been implicated in several serious conditions
including cancer, Parkinsons's disease and asthma. A
number of studies have previously shown heterologous
expression of this receptor in a range of expression hosts
including Escherichia coli [22], Pichia pastoris [16] and Sac-
charomyces cerevisae [23]. The A2AR expressed in E. coli was
sensitive to C-terminal proteolysis upon solubilisation
[22]. Recent studies have shown the importance of
removal of the unstructured C-terminal tail, among other
modifications, in obtaining well diffracting crystals and
ultimately structure determination of GPCRs [24,25]. The
A2AR has a particularly long C-terminal tail, comprised of
approximately 96 amino acid residues, likely to reduce the
chances of obtaining well diffracting crystals. Therefore
we also wished to assess the effects of generating a C-ter-
minal truncation on the functional expression and stabil-
ity of the receptor. A receptor construct was generated
truncating the protein at valine 334 (V334), a residue cor-
responding to the end of the rhodopsin C-terminal tail.
Using a previously described vector system [15] for
expression we have developed a large-scale fermentation
protocol which produces significantly higher levels of
functional A2AR than the equivalent volume of culture
using published shaker flask protocols [15,16]. This study
has also identified a C-terminally truncated version of the
A2AR receptor which is more highly expressed and more
stable than the WT. This construct may be more suitable
for downstream functional and structural studies.
Methods
Materials
Yeast nitrogen base and yeast extract were purchased from
Difco, peptone and L-histidine from Sigma-Aldrich and
dimethyl sulfoxide (DMSO) from Acros Organics. Com-Microbial Cell Factories 2008, 7:28 http://www.microbialcellfactories.com/content/7/1/28
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plete EDTA-free protease inhibitor cocktail tablets were
purchased from Roche and the bicinchoninic acid assay
(BCA) kit purchased from Pierce. Scintillation cocktail
(Ultima Gold MV) was obtained from PerkinElmer. [3H]
ZM 241385 was obtained from American Radiolabelled
Chemicals Inc. while ZM241385 was obtained from Toc-
ris and Theophylline from Fisher Scientific. Nitrocellulose
membrane was obtained from Millipore and GF/B filters
were from Whatman. The mouse M2 anti-FLAG antibody
was from Sigma-Aldrich and the sheep anti-mouse IgG-
horseradish peroxidase (HRP) conjugate from GE Health-
care. All other chemicals were obtained from Sigma-
Aldrich.
Expression constructs
The WT A2AR was expressed using a modified pPIC9K
(Invitrogen) vector incorporating a Flag tag followed by a
10 His tag and a TEV cleavage site all upstream of the gene
coding for the receptor as described by Andre et al, [15].
This vector was further modified to remove the Bio-tag
located downsteam of the gene coding for the receptor.
The forward primer 5'-GGT GGA TCC ATG CCC ATC ATG
GGC TCC TCG GTG TAC-3' together with the reverse
primer 5'-CAT GGA ATT CAC TAG TGA CCT GCT CTC
CGT CAC TGC CAT GAG CTG CCA AG-3' introducing a
stop codon after residue V334 was used to amplify the
truncated A2AR gene fragment. This amplified gene frag-
ment was sequenced and cloned into the BamHI and SpeI
restriction sites of the modified pPIC9K (Invitrogen) vec-
tor. Expression plasmids were transformed by electropo-
ration into SMD1163 P. pastoris cells.
Small scale cultures
Single P. pastoris colonies containing the plasmid of inter-
est were selected on YPD plates [1% (w/v) yeast extract,
2% (w/v) peptone, 2% (w/v) dextrose, 2% (w/v) agar]
containing 0.25% geneticin. Cells from a single colony
were used to inoculate 5 ml of BMGY medium [100 mM
potassium phosphate pH 6.0, 1% (w/v) yeast extract, 2%
(w/v) peptone, 1.34% (w/v) yeast nitrogen base without
amino acids, 0.00004% (w/v) biotin, 1% (w/v) glycerol].
The culture was grown overnight at 30°C to an OD600 of
12–15. The cells were spun down at 3,000 g for 5 min and
the cell pellet was resuspended in typically 10 ml BMMY
[similar to BMGY with the following changes: phosphate
buffer at pH 8.0, 2.5% (v/v) dimethyl sulfoxide, 0.04%
(w/v) histidine, and 0.5% (v/v) methanol instead of 1%
glycerol] to achieve a starting OD600 of 5 for all cultures.
The culture was incubated for 18 h at 22°C and then the
cells harvested by centrifugation at 5000 g for 5 mins. The
highest expressing clones were selected by Western blot
for further study.
Flask cultures
Single P. pastoris colonies from high expressing clone were
selected on YPD plates containing 0.25% geneticin. Cells
from a single colony were used to inoculate 50 ml of
BMGY medium. The culture was grown overnight at 30°C
to an OD600 of 3–5. A total of 500 ml of BMGY was inoc-
ulated with 25 ml of the starter culture and grown for 6–8
h to an OD600 of 5–10. The cells were spun down at 3,000
g for 20 min and the cell pellet was resuspended in 500 ml
BMMY. The culture was incubated for 20 h at 22°C and
then the cells harvested by centrifugation. Samples (1 ml)
were taken at various time points during expression (0, 4,
14, 16, 18, 20 hours post induction). The cells were har-
vested and stored at -80°C for further analysis.
Bioreactor cultures
Single P. pastoris colonies containing the plasmid of inter-
est were selected on YPD plates containing 0.25%
geneticin. Cells from a single colony were used to inocu-
late a 150 ml (or 500 ml for inoculation of a 20 L bioreac-
tor vessel) starter culture of MGY medium (0.1 M
potassium phosphate pH 6, 1.34% yeast nitrogen base,
0.0004% biotin, 1% glycerol). The culture was grown at
30°C with aeration for 18–22 hours to an OD600 ~10–15.
The entire inoculum was added to a 5 L fermenter vessel
at t = 0. Cultures were grown in a 5 L bioreactor vessel con-
trolled by an ADI 1010 bio-controller connected to a PC
running BioExpert software (all from Applikon Biotech-
nology). A methanol sensor (Raven Biotech) was used to
monitor and control methanol levels in the vessel. The
internal regulation software of the sensor was used to con-
trol the external peristaltic pump and adjust methanol
concentration to the set point. Agitation was set at 1000
rpm, pH at 5.0 and dO2 at 35% for the entire run. For the
initial cell growth phase the temperature was set at 30°C.
In this initial phase, the culture was allowed to consume
all the glycerol contained in the 4 L of FM22 culture
medium (4.3% (w/v) monobasic potassium phosphate,
0.5% (w/v) ammonium sulphate, 0.1% (w/v) calcium
sulphate, 1.43% (w/v) potassium sulphate, 1.17% (w/v)
magnesium sulphate) containing 2% (w/v) glycerol and 1
ml/L PMT4 trace elements solution (0.2% (w/v) copper
sulphate, 0.008% (w/v) sodium iodide, 0.3% (w/v) man-
ganese sulphate, 0.02% (w/v) sodium molybdate,
0.002% (w/v) boric acid, 0.05% (w/v) calcium sulphate,
0.05% (w/v) cobalt chloride, 0.7% (w/v) zinc chloride,
2.2% (w/v) iron sulphate, 0.02% (w/v) biotin, 1 ml/L sul-
phuric acid). During a second growth phase the culture
was fed 50% glycerol at a rate of 3.5 ml/L/h until the
OD600 reached approximately 75 (~3–4 h). The tempera-
ture of the vessel was then reduced to 22°C and the cells
treated with a 0.1% v/v aliquot of 100% methanol supple-
mented with 4 ml/L PMT4, 3% DMSO, 0.04% histidine
and the methanol sensor signal allowed to stabilise. The
signal output was recorded in mV and the methanol feed-Microbial Cell Factories 2008, 7:28 http://www.microbialcellfactories.com/content/7/1/28
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ing system set point was set to this value. The culture was
allowed to adapt to 0.1% methanol for 5 h. For the induc-
tion stage, the methanol concentration was raised to 0.5%
v/v in steps of 0.1% v/v every 2 to 3 hours. At the end of
the induction period (~18 h) the cells were harvested by
centrifugation at 3,000 g for 5 min. Samples (1 ml) were
taken at various time points during the culture (6, 4 and 2
hours pre induction and 0, 3, 6, 9, 12, 15, 18, and 21
hours post induction). The cells were harvested and stored
at -80°C for further analysis.
Membrane preparation
Cells were resuspended in ice-cold breaking buffer (50
mM HEPES-NaOH pH 7.4, 100 mM NaCl, 10% (w/v)
glycerol, 2 mM EDTA, 1 mM PMSF, 300 nM ZM241385,
(1/100 ml) PI), and broken using a tissue lyser (Qiagen)
set to 30 MHz for 15 mins. Cell debris, including intact
cells, were removed by a low speed spin (3,000 g) for 10
min. The supernatant was retained, and membranes iso-
lated by centrifugation at 100,000 g  for 30 min. Each
membrane pellet was re-dissolved in a membrane buffer
(50 mM HEPES-NaOH pH 7.4, 100 mM NaCl, 10% (w/v)
glycerol) and flash frozen in liquid nitrogen for storage.
Radioligand binding assays
All radioligand binding assays were performed using the
A2AR antagonist [3H] ZM241385 in binding buffer (20
mM HEPES, 1 mM EDTA, 1 mM EGTA, 0.1% BSA, pH
7.4). Single-point binding assays on yeast membrane-
bound receptor contained 2 μg of membrane protein in a
final volume of 1 ml in the presence of a saturating con-
centration (4 nM) of radioligand at 25°C for 3 hours.
Non-specific binding was determined in the presence of
10 mM theophylline, an A2AR antagonist and for each
time-point the assay was performed in triplicate. Follow-
ing incubation, bound and free radioligands were sepa-
rated on Whatman GF/B filters using a cell harvester
(Brandel). The filters were washed three times with ice-
cold phosphate buffered saline, and the amount of bound
radiolabel assessed using a LS 6500 scintillation counter
(Beckman Coulter). Binding data were analysed by non-
linear least squares fitting using the computer package
GraphPad Prism.
Protein concentration
All protein concentrations were determined by Lowry
assay using bovine serum albumin as standard [26].
SDS-PAGE and Western blotting
For Western-blot analysis the proteins were separated on
a 4–12% Bis-Tris NuPAGE gel prior to transfer to a PVDF
membrane using the X-Cell system (Invitrogen). The blot
was probed with 1:10,000 dilution of primary anti-FLAG
M2 (Sigma) antibody followed by a 1:10,000 dilution of
secondary goat anti-mouse horseradish peroxidase anti-
body. Protein bands were visualised using ECL substrate
(GE Biosciences).
Results
Bioreactors allow controlled cell growth
Figure 1 shows the changes in two parameters: dissolved
oxygen (dO2) and OD600 during a sample bioreactor cul-
ture for both WT A2AR (A) and V334 A2AR (B) constructs.
The initial glycerol batch phase (phase 1) showed a grad-
ual decrease in dissolved oxygen (dO2) levels followed by
a stabilisation at 35%, the configured set point. As the
cells multiply and consume glycerol, the culture's require-
ment for oxygen increased, lowering the observed dO2 in
the vessel. Once the 35% set point was reached, the sys-
tem maintained dO2 levels by modulating the airflow.
This ensured the culture did not starve of oxygen until all
the batch glycerol was exhausted. This phase lasted
approximately 22 hours with minor differences depend-
ing on the OD600 of the starting inoculum. A sharp rise in
dO2 after ~19 h cultivation indicated that the cells were
starving for glycerol and did not require oxygen to metab-
olise the carbon source. The glycerol fed-batch phase
(phase 2 on Figure 1) was then initiated. The culture was
fed 50% glycerol at 3.5 ml/L/hour until the OD600 reached
approximately 75. This caused dO2 levels to drop and sta-
bilise again at 35%. This phase lasted between 3 and 4
hours. The culture was then allowed to consume any
remaining glycerol before the start of the induction phase.
Protein expression was induced by the addition of metha-
nol. An adaptation period of 3–5 hours was required dur-
ing which the cells alter their metabolism to accept
methanol as the new carbon source. This was observed as
a steady decrease in dO2 levels as the cells slowly adapt to
methanol utilisation. During this phase the OD600
remained relatively stable at about 75 for the WT A2AR
construct while typically a small increase was observed for
the V334 A2AR (from 75 to ~80). The highly similar dO2
and OD600 traces for the two different constructs demon-
strate the reproducibility of the bioreactor culture proto-
col described in this study.
Western blot analysis of WT A2AR and V334 A2AR expressed 
in flask and bioreactor cultures
Expression of the two different receptors during the induc-
tion phase for both flask and bioreactor cultures was mon-
itored using both Western blot analysis and radioligand
binding assay. Western blot analysis of flask cultures
expressing WT A2AR showed a gradual increase in expres-
sion over the course of the induction phase with receptor
protein first detectable at 14 hours post induction (Figure
2A) as a band of approximately 38 kDa. Several larger
bands are also visible. These are likely to be due to differ-
ent oligomeric forms of the receptor formed as a result of
gel running conditions rather than representing the true
state of the receptor. Due to the large gap in samplingMicrobial Cell Factories 2008, 7:28 http://www.microbialcellfactories.com/content/7/1/28
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Comparison of key bioreactor culture parameters Figure 1
Comparison of key bioreactor culture parameters. Changes in OD600 (dashed line) and dissolved oxygen (solid line) 
over time during the bioreactor culture of the (A) WT A2AR and (B) V334 A2AR are indicated. Time periods indicated by the 
numbers correspond to (1) glycerol batch phase (2) glycerol fed-batch phase and (3) methanol induction phase.
 Microbial Cell Factories 2008, 7:28 http://www.microbialcellfactories.com/content/7/1/28
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Expression of the A2AR constructs over time Figure 2
Expression of the A2AR constructs over time. Western blot analysis of WT A2AR (A) and V334 A2AR (B) expressed in 
flask and WT A2AR (C) and V334 A2AR (D) in bioreactor cultures. Analysis was performed on membranes prepared from cells 
harvested at the different time points using anti-Flag antibody. M denotes the molecular weight markers and the numbers along 
the top of blots correspond to the time points.
 Microbial Cell Factories 2008, 7:28 http://www.microbialcellfactories.com/content/7/1/28
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times it is likely that receptor is expressed before 14 hours,
however it is clear that no receptor is expressed at 4 hours
post induction. The amount of WT A2AR did not seem to
significantly increase after this. The V334 A2AR expressed
in flasks (Figure 2B) was first detected as a band of approx-
imately 28 kDa at a similar time point however the
amount of protein increased significantly after this to the
20 hour time point where the culture was harvested.
Expression of the WT A2AR in the bioreactor also increased
with time although the expression was detectable by West-
ern blot at 3 hrs in contrast to the flask cultures (Figure
2C). A similar trend is observed for the V334 A2AR (Figure
2D). There were some low molecular weight bands visible
for the WT A2AR, indicating that there is proteolytic degra-
dation of the expressed receptor. The fact that these bands
are being detected using the N-terminally positioned Flag
tag suggests that the bands observed are due to C-terminal
degradation. This is not observed in the flask culture for
either construct, or the bioreactor culture expressing the
V334 A2AR. Interestingly however there is a distinctive
band visible at ~45 kDa for the V334 A2AR bioreactor sam-
ples which is not present in the flask culture for the same
construct. It is possible that the higher levels of expression
detected for the V334 A2AR in the bioreactor stimulates a
larger amount of dimer formation in the membrane.
Functional analysis of WT A2AR and V334 A2AR expressed 
in flask and bioreactor cultures
Radioligand binding analysis indicated a similar trend in
increasing expression of functional receptor from the flask
cultures. There was no measurable functional receptor for
the first 4 hours post induction (Figure 3A) while after this
time functional expression increased rapidly, as measured
at 14 hours. In the case of the WT A2AR the expression
level does not increase much after 14 hours with a final
expression level of 23 pmol/mg. The A2AR V334 construct
expresses to a much higher level after 14 hours (53 pmol/
mg) and increases significantly after that to a final expres-
sion level of 72 pmol/mg after 20 hour (Figure 3A). The
expression profile is slightly different in the case of the
bioreactor cultures. Derepression of the methanol pro-
moter due to depletion of the glycerol during the second
growth phase, induces expression from the AOX1 pro-
moter resulting in low level but measurable receptor pro-
duction prior to induction. For both the WT A2AR and the
V334 receptor constructs there is a steady increase in
expression up to 6 hours post induction (Figure 3B). After
this time the expression of the WT A2AR continues to
increase steadily peaking at approximately 125 pmol/mg
at the end of the culture (18 hrs) while A2AR V334
increases much faster peaking at 250 pmol/mg at 18 hrs
(Figure 3B). The culture for the V334 construct was con-
tinued for a further 3 hours however the data suggests that
this results in a slight drop in functional expression. It
may be that 18 hrs is the optimal harvesting time for the
bioreactor cultures.
Discussion
Flask versus bioreactor expression
The main aim of the study was to compare the expression
of A2AR in flask and bioreactor based cultures. The flask
conditions used in this study were similar to, or the same,
as those which have previously been used for expression
of the A2AR in P. pastoris [15,16]. Flask cultures enable the
exploration of several expression conditions in parallel
and require a limited set-up compared to bioreactor based
cultures. However there are a number of drawbacks to
flask cultures, which the bioreactor is particularly well
suited to overcome. The principal advantage of the biore-
Functional expression of the A2AR constructs over time Figure 3
Functional expression of the A2AR constructs over 
time. Radioligand binding analysis of both the WT A2AR 
(filled triangles) and V334 A2A R (filled circles) receptors 
expressed in flask (A) and bioreactor (B) cultures. Mem-
branes prepared from cells harvested at the different time 
points were assessed using radioligand binding assay using 
[3H] ZM241385. Induction of the cultures was initiated by 
addition of methanol at time 0 hours. Data shown are repre-
sentative of at least n = 2 experiments for each condition.Microbial Cell Factories 2008, 7:28 http://www.microbialcellfactories.com/content/7/1/28
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actor set up is that it enables large volumes of air to be cir-
culated within the culture to satisfy the high oxygenation
requirements of P. pastoris cultivation to high OD600. The
ability to regulate pH and dissolved oxygen (dO2) was
shown to greatly improve batch-to-batch reproducibility
while glycerol and methanol feeding lines enable accurate
control over the amount of nutrients added to the culture.
P. pastoris synthesises alcohol oxidase 1 (AOX1), which
metabolises methanol by conversion to formaldehyde.
However, if high concentrations of methanol are intro-
duced without pre-conditioning of the culture to this car-
bon source, excess formaldehyde can accumulate to toxic
levels to the cells [27]. It is therefore very important to
allow the culture to adapt to methanol utilisation using
low methanol concentration. Initial inductions per-
formed in the absence of accurate methanol control sys-
tematically produced very erratic expression profiles (data
not shown). The implementation of a methanol control
system proved essential for the reliability and reproduci-
bility of receptor expression.
The cell density achieved in the bioreactor cultures was
routinely almost six times higher than that achieved in
flask cultures as assessed by measurement of the OD600. In
addition radioligand binding indicated that there was an
approximately three and a half times higher functional
expression for the bioreactor culture compared to the flask
culture (summarised in Table 1). Thus the expression level
in the bioreactor is increased in two ways; 1) the biomass
is increased and 2) the production of functional receptor
is increased per mg of membrane protein. These data
clearly demonstrate the high efficiency receptor produc-
tion that can be achieved by the careful regulation and
optimisation of the growth parameters possible in biore-
actor cultures. It is likely that the protocol described here
is suitable for large scale production of other GPCRs in
bioreactors since increases in functional expression level
have also been obtained for the human dopamine D2 and
the human serotonin 5HT1D receptors compared to flask
cultures (data not shown).
Protein expression in the absence of inducer, so-called
leaky expression, is often observed when using recom-
binant systems [28]. The binding assay results indicated
that in the case of both the WT and V334 A2AR expressed
in bioreactors, receptor was present prior to methanol
induction. Glycerol represses the AOX1 promoter used for
A2AR expression and therefore no receptor should be
detected prior to the addition of methanol. However, as
the culture is allowed to fully deplete the glycerol present
in both glycerol batch and glycerol fed-batch phases,
some degree of derepression can occur, allowing some
protein to be synthesised. Ligand binding analysis also
indicated the presence of small amounts of receptor (max-
imally ~25 pmol/mg) in bioreactor samples taken prior to
induction with methanol. From published data, no more
than 2–4% of the total attainable amount of AOX1
induced protein is normally produced through derepres-
sion [29]. Interestingly, according to our measurements,
an estimated 10–15% receptor was produced in starvation
conditions. Functional analysis of the receptor produced
as a result of derepression indicates that A2AR produced
during derepression is correctly folded and functional.
The relatively low OD600 values achieved in flask cultures
mean it is unlikely that all the glycerol is consumed in the
glycerol batch phase explaining why no expression is
detectable at induction (time = 0 hours) due to derepres-
sion of the AOX1 promoter.
WT A2AR versus V334 A2AR functional expression
Radioligand binding analysis indicated that higher levels
of receptor were produced for the truncated V334 A2AR
compared to the WT A2AR in both flask and bioreactor cul-
tures with the V334 A2AR expressing at approximately
double the amount of the WT receptor (Table 1). The Bmax
value of 200 pmol/mg achieved for the V334 A2AR is the
highest reported value for functional expression of the
A2AR in P. pastoris. This is lower than that achieved for
expression of the A2AR in both S. cerevisae (480 pmol/mg;
[23]) and mammalian cells (287 pmol/mg; [30]). How-
ever the higher cell densities achieved using P. pastoris
mean that higher expression levels per litre are obtained.
Smaller bioreactors are required for P. pastoris growth than
for S. cerevisae making the cultures both cheaper and eas-
ier to handle.
Numerous studies have indicated that C-terminal trunca-
tion of GPCRs produces a much more stable protein,
more suitable for structural studies [24,25]. Western blot
analysis of the WT A2AR expressed in the bioreactor indi-
cated the presence of degradation bands likely to be the
result of C-terminal degradation. This is a major concern
Table 1: Cell densities and specific binding for the A2AR constructs expressed in flask and bioreactor cultures
Construct Cell density (OD600)* Maximum specific binding (pmol/mg)
Flask Bioreactor Flask Bioreactor
WT A2AR 14 75 32.5 ± 9.3 112.5 ± 2.7
A2AR V334 14 80 82.9 ± 11.2 200.6 ± 17.6
* cell density at inductionMicrobial Cell Factories 2008, 7:28 http://www.microbialcellfactories.com/content/7/1/28
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since the His-tag to be used for immobilised metal affinity
chromatography is N-terminally located. Thus, purifica-
tion would not differentiate between intact and degraded
receptor. In contrast the V334 A2AR does not exhibit this
degradation during expression. Previous studies express-
ing the WT A2AR in E. coli demonstrated C-terminal degra-
dation upon solubilisation [22]. In addition, work in our
group has shown C-terminal degradation of the WT A2AR
expressed in P. pastoris upon purification to high homoge-
neity (Singh et al, manuscript in preparation). These data
indicate an intrinsic instability in the WT A2AR. This deg-
radation has not been previously reported for expression
of the receptor in relatively small scale P. pastoris cultures
[16] and this is supported by the findings of this study
since no degradation bands were observed for either con-
struct in flask cultures. It may be that the very high expres-
sion levels achieved in the bioreactor reduces the
processing and targeting time of the receptor making it
more vulnerable to degradation by intracellular proteases.
The lack of degradation of the V334 A2AR indicates that
this is more stable and therefore a more suitable candidate
for further downstream structural and functional studies.
Recent work by Magnani et al, [31] describes the identifi-
cation of a number of mutants of the human A2AR with
increased thermostability and increased stability in short
chain detergents making them more suitable for crystalli-
sation. Mutant screening was performed in E. coli, how-
ever it maybe that the use of a eukaryotic system like the
large-scale P. pastoris system described in this manuscript
is more suitable for the production of the mutant recep-
tors for structural studies.
Conclusion
The use of P. pastoris bioreactor cultures has significant
advantages over traditional flask cultures for the expres-
sion of GPCRs for functional and structural studies. Biore-
actors yield higher cell densities as well as higher levels of
functional A2AR per mg of membrane protein compared
to flask cultures. Greater control of both cell growth and
induction conditions allow much greater reproducibility
of receptor expression. This study has also identified a
more stable truncated V334 A2AR construct for further
functional and structural studies.
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